QT
AXSM icon

Quantbot Technologies’s Axsome Therapeutics AXSM Stock Holding History

Quantbot Technologies’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.2K Buy
+99
New +$21.5K ﹤0.01% 1752
2026
Q1 		– Sell
-19,396
Closed -$3.54M – 1713
2025
Q4 		$3.54M Buy
19,396
+8,519
+78% +$1.19M 0.12% 265
2025
Q3 		$1.32M Sell
10,877
-7,717
-42% -$869K 0.04% 678
2025
Q2 		$1.94M Buy
18,594
+18,330
+6,943% +$1.94M 0.05% 532
2025
Q1 		$30.8K Buy
+264
New +$30.1K ﹤0.01% 1351
2022
Q3 		– Sell
-8,178
Closed -$313K – 1593
2022
Q2 		$313K Buy
8,178
+4,222
+107% +$134K 0.03% 759
2022
Q1 		$163K Buy
+3,956
New +$123K 0.01% 923
2020
Q1 		– Sell
-356
Closed -$36K – 916
2019
Q4 		$36K Sell
356
-2,970
-89% -$120K ﹤0.01% 994
2019
Q3 		$67K Buy
3,326
+770
+30% +$19.8K 0.01% 916
2019
Q2 		$65K Buy
+2,556
New +$51.2K 0.01% 847

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Quantbot Technologies's AXSM Position: Q2 2026 in Review

Quantbot Technologies opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 99 shares worth $24.2K. The stake represents ﹤0.01% of the portfolio and ranks #1752 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in AXSM as recently as Q4 2025.

Quantbot Technologies first reported a position in AXSM in Q2 2019 and has held it in 10 quarters since. The position peaked at $3.54M in Q4 2025. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Quantbot Technologies held 99 shares of Axsome Therapeutics worth $24.2K as of Q2 2026.
  • Axsome Therapeutics was a new Quantbot Technologies position in Q2 2026.
  • Axsome Therapeutics made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1752 holding.
  • Quantbot Technologies first reported a position in Axsome Therapeutics in Q2 2019 and has held it in 10 quarters since.
  • Quantbot Technologies's Axsome Therapeutics position peaked at $3.54M in Q4 2025.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.